The WACC of Hikma Pharmaceuticals PLC (HIK.L) is 9.0%.
Range | Selected | |
Cost of equity | 8.80% - 11.20% | 10.00% |
Tax rate | 20.90% - 22.90% | 21.90% |
Cost of debt | 4.90% - 6.40% | 5.65% |
WACC | 7.9% - 10.1% | 9.0% |
Category | Low | High |
Long-term bond rate | 4.0% | 4.5% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 0.8 | 0.89 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 8.80% | 11.20% |
Tax rate | 20.90% | 22.90% |
Debt/Equity ratio | 0.22 | 0.22 |
Cost of debt | 4.90% | 6.40% |
After-tax WACC | 7.9% | 10.1% |
Selected WACC | 9.0% | |